- Corporate Officers - M
- Morningside Venture Investments Ltd
Insider Trading History of Morningside Venture Investments Ltd
The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Morningside Venture Investments Ltd since 2017.
This trader's CIK number is 1543112.
At the time of last reporting, Morningside Venture Investments Ltd was the Officer of Apnimed, Inc.. (stock ticker symbol APMD).
Also see all insider trading activities at Apnimed, Inc..
Note that in the past
Morningside Venture Investments Ltd also reported insider trading activities as an insider of the following companies:
Yearly summary of insider trading at Apellis Pharmaceuticals, Inc. (APLS) by Morningside Venture Investments Ltd
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2021 | APLS | 250,000 | $10,000,000 | 0 | $0 | 0 | $0 |
| 2020 | APLS | 540,540 | $19,999,980 | 0 | $0 | 0 | $0 |
| 2019 | APLS | 441,176 | $7,499,992 | 0 | $0 | 0 | $0 |
| 2018 | APLS | 221,323 | $4,154,282 | 0 | $0 | 0 | $0 |
| 2017 | APLS | 575,000 | $8,050,000 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Amylyx Pharmaceuticals, Inc. (AMLX) by Morningside Venture Investments Ltd
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2023 | AMLX | 0 | $0 | 674,174 | $22,300,292 | 0 | $0 |
| 2022 | AMLX | 263,158 | $5,000,002 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Apnimed, Inc. (APMD) by Morningside Venture Investments Ltd
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2026 | APMD | 312,500 | $5,000,000 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Greenlight Biosciences Holdings, Pbc (GRNA) by Morningside Venture Investments Ltd
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2022 | GRNA | 4,061,224 | $11,999,998 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Kezar Life Sciences, Inc. (KZR) by Morningside Venture Investments Ltd
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2023 | KZR | 0 | $0 | 495,662 | $3,458,459 | 0 | $0 |
| 2020 | KZR | 3,800,000 | $9,880,000 | 0 | $0 | 0 | $0 |
| 2018 | KZR | 250,000 | $3,750,000 | 0 | $0 | 0 | $0 |
Insider trading activities at 5 companies by Morningside Venture Investments Ltd:
1. Apellis Pharmaceuticals, Inc. (APLS)
2. Amylyx Pharmaceuticals, Inc. (AMLX)
3. Apnimed, Inc. (APMD)
4. Greenlight Biosciences Holdings, Pbc (GRNA)
5. Kezar Life Sciences, Inc. (KZR)
Table 1. Insider trading of Apellis Pharmaceuticals, Inc. (APLS) by Morningside Venture Investments Ltd
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2021-11-18 | APLS | Buy | 250,000 | 40.00 | 10,000,000 |
| 2020-01-13 | APLS | Buy | 540,540 | 37.00 | 19,999,980 |
| 2019-03-11 | APLS | Buy | 441,176 | 17.00 | 7,499,992 |
| 2018-09-20 | APLS | Buy | 41,323 | 19.11 | 789,682 |
| 2018-09-21 | APLS | Buy | 40,000 | 19.84 | 793,600 |
| 2018-09-17 | APLS | Buy | 40,000 | 18.67 | 746,800 |
| 2018-09-18 | APLS | Buy | 40,000 | 18.47 | 738,800 |
| 2018-09-19 | APLS | Buy | 60,000 | 18.09 | 1,085,400 |
| 2017-11-13 | APLS | Buy | 575,000 | 14.00 | 8,050,000 |
Table 2. Insider trading of Amylyx Pharmaceuticals, Inc. (AMLX) by Morningside Venture Investments Ltd
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2023-03-29 | AMLX | Sale | 29,048 | 30.45 | 884,511 |
| 2023-03-28 | AMLX | Sale | 100,000 | 30.37 | 3,037,000 |
| 2023-03-27 | AMLX | Sale | 60,964 | 30.52 | 1,860,926 |
| 2023-03-21 | AMLX | Sale | 63,448 | 31.93 | 2,025,894 |
| 2023-03-15 | AMLX | Sale | 150,000 | 33.40 | 5,010,000 |
| 2023-03-14 | AMLX | Sale | 70,714 | 34.54 | 2,442,461 |
| 2023-03-02 | AMLX | Sale | 50,000 | 33.75 | 1,687,500 |
| 2023-02-22 | AMLX | Sale | 50,000 | 35.02 | 1,751,000 |
| 2023-02-23 | AMLX | Sale | 50,000 | 35.90 | 1,794,750 |
| 2023-02-22 | AMLX | Sale | 50,000 | 36.12 | 1,806,250 |
| 2022-01-11 | AMLX | Buy | 263,158 | 19.00 | 5,000,002 |
Table 3. Insider trading of Apnimed, Inc. (APMD) by Morningside Venture Investments Ltd
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2026-08-03 | APMD | Buy | 312,500 | 16.00 | 5,000,000 |
Table 4. Insider trading of Greenlight Biosciences Holdings, Pbc (GRNA) by Morningside Venture Investments Ltd
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2022-08-11 | GRNA | Buy | 3,061,224 | 3.92 | 11,999,998 |
| 2022-02-02 | ENVI | Buy | 1,000,000 | .00 | 0 |
Table 5. Insider trading of Kezar Life Sciences, Inc. (KZR) by Morningside Venture Investments Ltd
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2023-02-03 | KZR | Sale | 25,000 | 7.15 | 178,650 |
| 2023-02-06 | KZR | Sale | 40,000 | 6.88 | 275,320 |
| 2023-02-01 | KZR | Sale | 40,000 | 6.95 | 278,000 |
| 2023-02-02 | KZR | Sale | 50,000 | 7.19 | 359,500 |
| 2023-01-30 | KZR | Sale | 30,000 | 6.91 | 207,300 |
| 2023-01-31 | KZR | Sale | 30,000 | 7.08 | 212,400 |
| 2023-01-25 | KZR | Sale | 50,000 | 6.85 | 342,500 |
| 2023-01-23 | KZR | Sale | 80,000 | 6.81 | 544,800 |
| 2023-01-24 | KZR | Sale | 80,000 | 6.98 | 558,400 |
| 2023-01-05 | KZR | Sale | 12,162 | 6.97 | 84,769 |
| 2023-01-06 | KZR | Sale | 3,000 | 6.89 | 20,670 |
| 2023-01-03 | KZR | Sale | 500 | 7.10 | 3,550 |
| 2022-12-29 | KZR | Sale | 25,000 | 7.10 | 177,500 |
| 2023-01-04 | KZR | Sale | 30,000 | 7.17 | 215,100 |
| 2020-02-04 | KZR | Buy | 3,800,000 | 2.60 | 9,880,000 |
| 2018-06-25 | KZR | Buy | 250,000 | 15.00 | 3,750,000 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Morningside Venture Investments Ltd
(Officer of Apnimed, Inc. at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.